FDA Inspection
Lato Drug Co. Inc. dba Post Haste PharmacyLato Drug Co. Inc. dba Post Haste Pharmacy – FDA Inspection, Feb 20, 2015
Record Details
This FDA Inspection record concerns Lato Drug Co. Inc. dba Post Haste Pharmacy, with an inspection on February 20, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 20, 2015
- Product Type
- Drugs
View Company Profile
ID · 8b55658f-7bd7-47af-b012-e5edf4b652dd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 917948
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lato Drug Co. Inc. dba Post Haste Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lato Drug Co. Inc. dba Post Haste Pharmacy
- FDA Inspection 1008518 - 2017-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.